(Q53704925)

18 May 2018

title

Acadesine and lipopolysaccharide-evoked pulmonary dysfunction after resuscitation from traumatic shock. (English)

1 reference

18 May 2018

0 references

1 reference

Fabian TC

1

1 reference

18 May 2018

Fabian MJ

series ordinal

2

1 reference

18 May 2018

Yockey JM

series ordinal

3

1 reference

18 May 2018

Proctor KG

series ordinal

4

1 reference

18 May 2018

language of work or name

1 reference

1 March 1996

1 reference

18 May 2018

published in

Surgery

1 reference

18 May 2018

volume

119

1 reference

18 May 2018

issue

3

1 reference

18 May 2018

page(s)

302-315

1 reference

18 May 2018

Acadesine: the prototype adenosine regulating agent for reducing myocardial ischaemic injury

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

Increased adenosine concentration in blood from ischemic myocardium by AICA riboside. Effects on flow, granulocytes, and injury

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

5-Amino-4-imidazolecarboxaimide riboside raises adenosine in perfused hypoxic rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

Acadesine (AICA-riboside) improves postischemic cardiac recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

Sustained protection by acadesine against ischemia- and reperfusion-induced injury. Studies in the transplanted rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

Acadesine and myocardial protection. Studies of time of administration and dose-response relations in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

AICA-riboside: safety, tolerance, and pharmacokinetics of a novel adenosine-regulating agent

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

Acadesine (AICA-riboside): disposition and metabolism of an adenosine-regulating agent

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

An initial multicenter, randomized controlled trial on the safety and efficacy of acadesine in patients undergoing coronary artery bypass graft surgery. SPI Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

5-Aminoimidazole-4-carboxamide riboside (AICAr) administration reduces cerebral ischemic damage in the Mongolian gerbil.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

Extracellular and intracellular actions of adenosine and related compounds in the reperfused rat intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

Actions of adenosine on nitro blue tetrazolium deposition and surface pH during intestinal reperfusion injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

Gastric and extragastric actions of the histamine antagonist ranitidine during posttraumatic sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

Neutrophil CD18 expression and blockade after traumatic shock and endotoxin challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

Reduced tumor necrosis factor production in endotoxin-spiked whole blood after trauma: Experimental results and clinical correlation*

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

Adenosine, an endogenous anti-inflammatory agent

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

In vivo behavior of neutrophils from two patients with distinct inherited leukocyte adhesion deficiency syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

Protective effects of adenosine in myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

Mechanism of the beneficial effects of ATP-MgCl2 following trauma-hemorrhage and resuscitation: Downregulation of inflammatory cytokine (TNF, IL-6) release

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

Elaboration of interleukin 1-receptor antagonist is not attenuated by glucocorticoids after endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

Inhibition of Neutrophil Superoxide Production by Adenosine Released from Vascular Endothelial Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

Adenosine contributes to neutrophil-mediated loss of myocardial function in post-ischemic guinea-pig hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

Rat brain adenosine deaminase after 2'-deoxycoformycin administration: biochemical properties and evidence for reduced enzyme levels detected by 2'-[3H]deoxycoformycin ligand binding

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

Pentostatin: an adenosine deaminase inhibitor for the treatment of hairy cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980117-6

7 January 2021

10.1016/S0039-6060(96)80117-6

Identifiers

DOI

1 reference

18 May 2018

1 reference

18 May 2018